Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Clinical, Cosmetic and Investigational Dermatology Volume 16, 2023 - Issue

Submit an article Journal homepage

Open access

275

Views

CrossRef citations to date

Altmetric

REVIEW

Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing

Tamara Gracia-CazañaDermatology Service, Hospital Miguel Servet, IIS Aragon, Zaragoza University, Zaragoza, SpainCorrespondence[email protected]
View further author information

Laura Bernal-MasferrerDermatology Service, Hospital Miguel Servet, IIS Aragon, Zaragoza University, Zaragoza, SpainView further author information

Ana María Morales-CallaghanDermatology Service, Hospital Miguel Servet, IIS Aragon, Zaragoza University, Zaragoza, SpainView further author information

Manuel Almenara-BlascoDermatology Service, Hospital Miguel Servet, IIS Aragon, Zaragoza University, Zaragoza, SpainView further author information

Yolanda GilaberteDermatology Service, Hospital Miguel Servet, IIS Aragon, Zaragoza University, Zaragoza, SpainView further author information

Pages 221-229 | Received 06 Oct 2022, Accepted 17 Jan 2023, Published online: 25 Jan 2023

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Laura Huth, Philipp M. Amann, Yvonne Marquardt, Manuela Jansen, Jens Malte Baron & Sebastian Huth. (2024) Understanding the impact of risankizumab on keratinocyte-derived IL-23A in a novel organotypic 3D skin model containing IL-23A responsive and IL-17A producing γδ-T-cells. Cutaneous and Ocular Toxicology 0:0, pages 1-5.
Read now

Articles from other publishers (1)

Fabrizio Calapai, Ilaria Ammendolia, Luigi Cardia, Mariaconcetta Currò, Gioacchino Calapai, Emanuela Esposito & Carmen Mannucci. (2023) Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database. Pharmaceutics 15:7, pages 1933.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references